Processa Pharmaceuticals Inc
(PCSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | |
| Assets | ||
| Current Assets | ||
| Receivables | 1 | N/A |
| Inventories | 219 | N/A |
| Other current assets | 55 | 0 |
| TOTAL | $383 | $N/A |
| Non-Current Assets | ||
| PPE Net | 359 | N/A |
| Intangibles | 1,696 | 0 |
| Other Non-Current Assets | 107 | 0 |
| TOTAL | $2,163 | $N/A |
| Total Assets | $2,546 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 20 | N/A |
| Accounts payable and accrued liabilities | 154 | 0 |
| Accrued Expenses | 102 | N/A |
| TOTAL | $844 | $N/A |
| Non-Current Liabilities | ||
| Long Term Debt | 494 | N/A |
| Deferred Revenues | 58 | N/A |
| TOTAL | $494 | $N/A |
| Total Liabilities | $1,338 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 1 | N/A |
| Retained earnings | -11,849 | N/A |
| Other shareholders' equity | -1,056 | 0 |
| TOTAL | $1,208 | $N/A |
| Total Liabilities And Equity | $2,546 | $0 |